Hackman Acquires FENNEC PHARMACEUTICALS INC. Shares

Jeffrey S. Hackman, Chief Executive Officer and Director of FENNEC PHARMACEUTICALS INC., acquired 1159 shares of common stock on April 30, 2026. The acquisition was a result of shares being released from restriction, which were initially awarded on March 28, 2025. The transaction code is "M", indicating a grant, award, or settlement, and the shares were acquired ("A"). The price per share was $0.00. Following this transaction, Hackman now directly owns 61,666 shares of FENNEC PHARMACEUTICALS INC. common stock. The reporting signature date was May 1, 2026.